NRIM 29.03 Northrim Bancorp Inc $NRIM Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
NRIM 29.03 Northrim Bancorp Inc $NRIM Hit a 52 week high of 29.13 Currently at 29.03 +0.43 +1.50% With a day low of 28.48 and a total volume of 11,700.

NRIM Northrim Bancorp Inc Recent Headline News

Northrim BanCorp Up 11.3% Since SmarTrend Uptrend Call (NRIM)
Comtex SmarTrend(R) - Thu Nov 06, 10:06AM CST
SmarTrend identified an Uptrend for Northrim BanCorp (NASDAQ:NRIM) on September 12th, 2014 at $25.66. In approximately 2 months, Northrim BanCorp has returned 11.34% as of today's recent price of $28.57.
NRIM: 29.04 (+0.01)

Northrim BanCorp Shares Up 10.0% Since SmarTrend's Buy Recommendation (NRIM)
Comtex SmarTrend(R) - Thu Oct 30, 9:35AM CDT
SmarTrend identified an Uptrend for Northrim BanCorp (NASDAQ:NRIM) on September 12th, 2014 at $25.66. In approximately 2 months, Northrim BanCorp has returned 9.98% as of today's recent price of $28.22.
NRIM: 29.04 (+0.01)

Northrim BanCorp Has Returned 10.8% Since SmarTrend Recommendation (NRIM)
Comtex SmarTrend(R) - Wed Oct 22, 10:13AM CDT
SmarTrend identified an Uptrend for Northrim BanCorp (NASDAQ:NRIM) on September 12th, 2014 at $25.66. In approximately 1 month, Northrim BanCorp has returned 10.83% as of today's recent price of $28.44.
NRIM: 29.04 (+0.01)

Northrim BanCorp Earns $3.7 Million, or $0.53 Per Diluted Share, in Q314
GlobeNewswire - Tue Oct 21, 3:00PM CDT
Northrim BanCorp, Inc. (Nasdaq:NRIM) ("Northrim" today reported net profits of $3.7 million, or $0.53 per diluted share, for the third quarter of 2014, compared to $4.4 million, or $0.63 per diluted share, in the second quarter of 2014 and $3.5 million, or $0.53 per diluted share, in the third quarter a year ago. Contributions from the acquisition of Alaska Pacific Bancshares, Inc. ("Alaska Pacific" increased revenues and helped provide a stable net interest margin, while costs associated with the acquisition of Alaska Pacific and the pending acquisition of Residential Mortgage Holding Company, LLC, the parent company of Residential Mortgage, LLC ("Residential Mortgage" increased third quarter 2014 operating costs. Year-to-date 2014, net profits increased 11% to $10.7 million, or $1.57 per diluted share, compared to $9.6 million, or $1.46 per diluted share, in the first nine months of 2013.
NRIM: 29.04 (+0.01)

Northern Trust Offers Improved IAS19 Solution to Clients - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 01, 10:15AM CDT
Northern Trust (NTRS) revealed an enhanced reporting solution for the pension fund clients to fulfil the International Accounting Standard 19 (IAS19) requirements as stated under the International Financial Reporting Standards (IFRS).
LION: 15.08 (-0.14), NTRS: 67.01 (+0.11), NRIM: 29.04 (+0.01), NBCB: 37.17 (+0.09)

Preferred Bank Up to Strong Buy on Legacy Issues Resolution - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 30, 4:40PM CDT
On Sep 30, Zacks Investment Research upgraded Preferred Bank (PFBC) to a Zacks Rank #1 (Strong Buy).
PFBC: 26.30 (+0.06), SIVB: 113.95 (+0.95), BSRR: 17.40 (+0.19), NRIM: 29.04 (+0.01)

Will BankUnited's Rising Expenses Dampen Upcoming Results? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 30, 10:20AM CDT
On Sep 24, 2014, we issued an updated research report on BankUnited (BKU).
MRCC: 13.87 (-0.02), AB: 26.20 (-0.05), NRIM: 29.04 (+0.01), BKU: 30.32 (+0.04)

Will Affiliated Managers' Portfolio Expansion Show Results? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 26, 10:20AM CDT
On Sep 19, 2014, we issued an updated research report on Affiliated Managers (AMG).
MRCC: 13.87 (-0.02), AB: 26.20 (-0.05), AMG: 195.91 (-0.79), NRIM: 29.04 (+0.01)

BofI Holding Up to Strong Buy on Robust Fiscal Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 5:25PM CDT
On Sep 25, Zacks Investment Research upgraded BofI Holding, Inc. (BOFI) to a Zacks Rank #1 (Strong Buy).
BOFI: 78.23 (+0.24), CATY: 26.40 (+0.11), BSRR: 17.40 (+0.19), NRIM: 29.04 (+0.01)

JPMorgan's Streamlining Continues: Sells HSAs to Webster - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 6:00PM CDT
JPMorgan (JPM) signed a definitive contract with Webster (WBS) to sell the health savings account (HSA) business managed by its subsidiary, JPMorgan Chase Bank, N.A.
JPM: 61.73 (+0.26), BANC: 11.72 (+0.10), NRIM: 29.04 (+0.01), WBS: 31.99 (+0.13)

Will Westamerica's Top Line Revive or Remain a Concern? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 5:45PM CDT
On Sep 17, 2014, we issued an updated research report on Westamerica (WABC). Prudent expense management continued to be encouraging, whereas stressed top-line growth remained a concern.
WABC: 50.07 (+0.11), BANC: 11.72 (+0.10), BSRR: 17.40 (+0.19), NRIM: 29.04 (+0.01)

Zions' Organic Growth on Track, Should You Stay Invested? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 09, 4:35PM CDT
On Sep 4, 2014, we issued an updated research report on Zions (ZION).
BSRR: 17.40 (+0.19), CVCY: 10.83 (-0.16), NRIM: 29.04 (+0.01), ZION: 29.66 (-0.01)

PrivateBancorp to Redeem $75M Trust Preferred Securities - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 09, 3:55PM CDT
PrivateBancorp, Inc. (PVTB) announced it decision to redeem $75.0 million of its $143.8 million issued and outstanding 10.00% trust preferred securities (TruPS).
STBA: 27.65 (+0.04), PVTB: 32.79 (-0.10), FSGI: 1.97 (unch), NRIM: 29.04 (+0.01)

BNY Mellon Faces Top-Line Pressure; Will You Hold the Stock? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 08, 10:10AM CDT
On Sep 1, 2014, we issued an updated research report on BNY Mellon. Robust growth in assets under management (AUM) remained the key strength of BNY Mellon, but the pressurized top line continued to be a chief concern.
FFKT: 23.01 (+0.20), BSRR: 17.40 (+0.19), NRIM: 29.04 (+0.01), BK: 39.33 (+0.42)

First Republic (FRC) Stock Missed the Rally: Time to Dump It? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 4:15PM CDT
On Sep 2, 2014, we issued an updated research report on First Republic Bank (FRC).
BSRR: 17.40 (+0.19), FRC: 51.57 (+0.02), CVCY: 10.83 (-0.16), NRIM: 29.04 (+0.01)

BB&T Expands Globally Despite Revenue & Expense Pressure - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 27, 10:20AM CDT
We issued an updated research report on BB&T Corporation (BBT) on Aug 25, 2014. The company recently reported dismal second-quarter 2014 results.
BBT: 38.37 (+0.19), BSRR: 17.40 (+0.19), CVCY: 10.83 (-0.16), NRIM: 29.04 (+0.01)

Bank of Marin Hits New 52-Week High on Solid Q2 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 2:50PM CDT
Shares of Bank of Marin achieved a new 52-week high of $48.00 in the second half of the trading session on Aug 21. The stock closed the session at $47.66, reflecting a year-to-date return of 10.6%. The trading volume for the session was 41,882 shares.
BSRR: 17.40 (+0.19), CVCY: 10.83 (-0.16), NRIM: 29.04 (+0.01), BMRC: 50.63 (+1.03)

Northrim Bancorp Up to Strong Buy on Recent Acquisition News - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 4:40PM CDT
On Aug 12, Zacks Investment Research upgraded Northrim Bancorp Inc. (NRIM) to a Zacks Rank #1 (Strong Buy).
BSRR: 17.40 (+0.19), CVCY: 10.83 (-0.16), GSBC: 39.66 (+0.92), NRIM: 29.04 (+0.01)

Northrim BanCorp to Acquire Residential Mortgage, LLC for $29.8 Million
GlobeNewswire - Thu Aug 07, 8:31AM CDT
Northrim BanCorp, Inc. ("Northrim" (Nasdaq:NRIM) and Residential Mortgage Holding Company, LLC, ("RML" today jointly announced the signing of a definitive purchase agreement (the "Purchase Agreement" for a wholly-owned subsidiary of Northrim Bank, Northrim Capital Investment Company ("NCIC", to acquire 76.5% of the membership interests in RML, the parent company of Residential Mortgage, LLC ("Residential Mortgage" in a cash transaction currently valued at $29.8 million.
NRIM: 29.04 (+0.01)

Is Northrim Bancorp (NRIM) Stock a Solid Choice Right Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Aug 06, 7:46AM CDT
Northrim Bancorp is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
NRIM: 29.04 (+0.01)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 61

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 69

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 181

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 28

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 80

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 252

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 331

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Cisco's Chief Discusses Entry-Level Hiring Trends and AI

Updated Category News Views 192

Cisco's Insights on Entry-Level Hiring Trends The landscape of entry-level job opportunities is seeing a notable shift. Data from an industry student platform reveals a decrease in job postings for recent graduates. The statistics indicate a 16% year-over-year drop in entry-level positions, sparking concern among graduates and job seekers. Understanding the Current Job...

Continue Reading
FMC’s Rimisoxafen: The Game-Changer Amid Weeds' Rebellion

Updated Category News Views 248

FMC's Bold Move in the Herbicide Game Honestly, this takes me back to the dot-com era—not in tech, but in agriculture. FMC Corporation (NYSE:FMC) just pulled a doozy by getting rimisoxafen classified as a dual mode of action herbicide. This baby’s not just a gimmick; it’s a big deal for a sector that's wrestling down weeds like Palmer amaranth that’ve become a...

Continue Reading
Chord Energy Announces Earnings Call for Q2 2025 Results

Updated Category News Views 168

Chord Energy Earnings Release and Conference Call Details Chord Energy Corp. (NASDAQ: CHRD) has exciting news as it gears up to announce its financial and operational results for the second quarter of 2025. This announcement is scheduled to occur after the market closes, on an appointed date that follows the pattern of previous releases. Live Webcast and Conference Call...

Continue Reading
TuniTuni Thrives Globally with Unique Storytelling Approach

Updated Category News Views 338

TuniTuni: A Global Pioneer in Toddler Development TuniTuni is redefining early childhood physical education through its innovative approach that combines storytelling with the essential elements of physical movement. Since its inception in 2003, this leading brand has garnered attention in various regions, particularly emphasizing the importance of physical activity for...

Continue Reading
Investigation into Open Lending Holdings for Investor Losses

Updated Category News Views 363

Investigation into Open Lending Holdings for Investor Losses Faruqi & Faruqi, LLP is taking steps to look into potential claims on behalf of investors who have faced considerable losses related to Open Lending Corporation (NASDAQ: LPRO). If you have experienced financial setbacks from your investments in Open Lending, it’s important to know that you're not alone and...

Continue Reading